Assessment of national reimbursement anticancer medications availability in China: based on a medical institution perspective

• Main Authors: Wenxin Meng (Author), Shudi Yang (Author), Zhangke Wang (Author), Jinping Xie (Author), Rong Jiang (Author)
• Format: Knjiga
• Izdano: BMC, 2024-08-01T00:00:00Z.
• Teme: article
• Online dostop: Connect to this object online.

Abstract Background High clinical value national reimbursement anticancer medications (NRAMs) are pivotal treatments for patients with cancer. However, the availability of NRAMs in medical institutions is unknown. This study aimed to assess the availability of NRAMs in national and provincial medica...